Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Dyslipidemia

Free Subscription Articles published in J Clin Endocrinol Metab Retrieve available abstracts of 32 articles: HTML format

Single Articles

September 2021
1. AGUILAR-RAMIREZ D, Alegre-Diaz J, Herrington WG, Staplin N, et al
   Association of Kidney Function With NMR-Quantified Lipids, Lipoproteins, and Metabolic Measures in Mexican Adults.
   J Clin Endocrinol Metab. 2021;106:2828-2839.
   PubMed     Abstract available
   
   
   August 2021
2. PAQUETTE M, Amyot J, Fantino M, Baass A, et al
   Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.
   J Clin Endocrinol Metab. 2021;106:e3473-e3482.
   PubMed     Abstract available
   
   
   June 2021
3. MIYAMURA K, Nawa N, Isumi A, Doi S, et al
   The Association of Passive Smoking and Dyslipidemia Among Adolescence in Japan: Results From A-CHILD Study.
   J Clin Endocrinol Metab. 2021;106:e2738-e2748.
   PubMed     Abstract available
   
   
   April 2021
4. KIYA M, Tamura Y, Takeno K, Someya Y, et al
   Adipose Insulin Resistance and Decreased Adiponectin Are Correlated With Metabolic Abnormalities in Nonobese Men.
   J Clin Endocrinol Metab. 2021;106:e2228-e2238.
   PubMed     Abstract available
   
   
   March 2021
5. BELHASSEN M, Van Ganse E, Nolin M, Berard M, et al
   10-Year Comparative Follow-up of Familial versus Multifactorial Chylomicronemia Syndromes.
   J Clin Endocrinol Metab. 2021;106:e1332-e1342.
   PubMed     Abstract available
   
   
   
6. GRANT LK, Czeisler CA, Lockley SW, Rahman SA, et al
   Time-of-day and Meal Size Effects on Clinical Lipid Markers.
   J Clin Endocrinol Metab. 2021;106:e1373-e1379.
   PubMed     Abstract available
   
   
   
7. YEN CL, Fan PC, Lin MS, Lee CC, et al
   Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk among Patients with Advanced CKD.
   J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156972. doi: 10.1210.
   PubMed     Abstract available
   
   
   
8. MORYS F, Dadar M, Dagher A
   Association between mid-life obesity, its metabolic consequences, cerebrovascular disease and cognitive decline.
   J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156963. doi: 10.1210.
   PubMed     Abstract available
   
   
   February 2021
9. STINSON SE, Jonsson AE, Lund MAV, Frithioff-Bojsoe C, et al
   Fasting plasma GLP-1 associates with overweight/obesity and cardiometabolic risk factors in children and adolescents.
   J Clin Endocrinol Metab. 2021 Feb 17. pii: 6141463. doi: 10.1210.
   PubMed     Abstract available
   
   
   
10. NGAOSUWAN K, Johnston DG, Godsland IF, Cox J, et al
    Cardiovascular disease in patients with primary and secondary adrenal insufficiency and the role of comorbidities.
    J Clin Endocrinol Metab. 2021 Feb 15. pii: 6135110. doi: 10.1210.
    PubMed     Abstract available
    
    
    
11. MORAN C, McEniery CM, Schoenmakers N, Mitchell C, et al
    Dyslipidemia, insulin resistance, ectopic lipid accumulation and vascular function in Resistance to Thyroid Hormone beta.
    J Clin Endocrinol Metab. 2021 Feb 1. pii: 6125725. doi: 10.1210.
    PubMed     Abstract available
    
    
    January 2021
12. LUUKKONEN PK, Qadri S, Lehtimaki TE, Juuti A, et al
    The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients.
    J Clin Endocrinol Metab. 2021;106:e300-e315.
    PubMed     Abstract available
    
    
    December 2020
13. NEWMAN CB, Blaha MJ, Boord JB, Cariou B, et al
    Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    October 2020
14. FERCHAUD-ROUCHER V, Zair Y, Aguesse A, Krempf M, et al
    Omega 3 Improves Both apoB100-containing Lipoprotein Turnover and their Sphingolipid Profile in Hypertriglyceridemia.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    September 2020
15. KOTWAL A, Cortes T, Genere N, Hamidi O, et al
    Treatment of Thyroid Dysfunction and Serum Lipids: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2020 Sep 21. pii: 5909289. doi: 10.1210.
    PubMed     Abstract available
    
    
    May 2020
16. KOZAKOVA M, Morizzo C, Penno G, Shore AC, et al
    Plasma Homocysteine and Cardiovascular Organ Damage in a Population with a High Prevalence of Risk Factors.
    J Clin Endocrinol Metab. 2020 May 26. pii: 5846189. doi: 10.1210.
    PubMed     Abstract available
    
    
    April 2020
17. MORALES-PALOMO F, Ramirez-Jimenez M, Ortega JF, Moreno-Cabanas A, et al
    Exercise Training Adaptations in Metabolic Syndrome Individuals on Chronic Statin Treatment.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    
18. LANGSTED A, Jensen AMR, Varbo A, Nordestgaard BG, et al
    Low High-Density Lipoprotein Cholesterol to Monitor Long-Term Average Increased Triglycerides.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    March 2020
19. FANG S, Zhang S, Huang Y, Wu Y, et al
    Evidence for associations between Th1/Th17 "hybrid" phenotype and altered lipometabolism in very severe Graves' orbitopathy.
    J Clin Endocrinol Metab. 2020 Mar 16. pii: 5805506. doi: 10.1210.
    PubMed     Abstract available
    
    
    
20. HSIUNG CN, Chang YC, Lin CW, Chang CW, et al
    The Causal Relationship of Circulating Triglyceride and Glycated Hemoglobin: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available
    
    
    January 2020
21. KELSEY MM, Pyle L, Hilkin A, Severn CD, et al
    The impact of obesity on insulin sensitivity and secretion during pubertal progression: a longitudinal study.
    J Clin Endocrinol Metab. 2020 Jan 30. pii: 5717690. doi: 10.1210.
    PubMed     Abstract available
    
    
    
22. SHAH VN, Bailey R, Wu M, Foster NC, et al
    Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.
    J Clin Endocrinol Metab. 2020 Jan 19. pii: 5709622. doi: 10.1210.
    PubMed     Abstract available
    
    
    December 2019
23. HIGGINS V, Omidi A, Tahmasebi H, Asgari S, et al
    Marked influence of adiposity on laboratory biomarkers in a healthy cohort of children and adolescents.
    J Clin Endocrinol Metab. 2019 Dec 17. pii: 5675353. doi: 10.1210.
    PubMed     Abstract available
    
    
    
24. HIGGINS V, Asgari S, Hamilton JK, Wolska A, et al
    Postprandial dyslipidemia, hyperinsulinemia, and impaired gut peptides/bile acids in adolescents with obesity.
    J Clin Endocrinol Metab. 2019 Dec 11. pii: 5673404. doi: 10.1210.
    PubMed     Abstract available
    
    
    July 2019
25. KAHKOSKA AR, Nguyen CT, Adair LA, Aiello AE, et al
    Longitudinal phenotypes of type 1 diabetes in youth based on weight and glycemia and their association with complications.
    J Clin Endocrinol Metab. 2019 Jul 10. pii: 5530245. doi: 10.1210/jc.2019-00734.
    PubMed     Abstract available
    
    
    June 2019
26. VAN IERSEL L, Xu J, Potter B, Conklin HM, et al
    Clinical Importance of Free Thyroxine Concentration Decline after Radiotherapy for Pediatric and Adolescent Brain Tumors.
    J Clin Endocrinol Metab. 2019 Jun 7. pii: 5511532. doi: 10.1210/jc.2019-00539.
    PubMed     Abstract available
    
    
    
27. MULLER-WIELAND D, Rader DJ, Moriarty PM, Bergeron J, et al
    Efficacy and Safety of Alirocumab 300 mg Every 4 Weeks in Individuals with Type 2 Diabetes on Maximally Tolerated Statin.
    J Clin Endocrinol Metab. 2019 Jun 5. pii: 5510497. doi: 10.1210/jc.2018-02703.
    PubMed     Abstract available
    
    
    May 2019
28. LEROITH D, Biessels GJ, Braithwaite SS, Casanueva FF, et al
    Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2019;104:1520-1574.
    PubMed     Abstract available
    
    
    February 2019
29. LEE JY, Han K, Han E, Kim G, et al
    Risk of Incident Dementia According to Metabolic Health and Obesity Status in Late-life: a Population-based Cohort Study.
    J Clin Endocrinol Metab. 2019 Feb 25. pii: 5364430. doi: 10.1210/jc.2018-01491.
    PubMed     Abstract available
    
    
    
30. SCHADE DS, Eaton RP
    A Simplified Approach to Reducing Cardiovascular Risk.
    J Clin Endocrinol Metab. 2019 Feb 20. pii: 5342943. doi: 10.1210/jc.2018-02509.
    PubMed     Abstract available
    
    
    
31. BEHESHTI S, Madsen CM, Varbo A, Nordestgaard BG, et al
    How to identify familial premature myocardial infarction: comparing approaches to identify familial hypercholesterolemia.
    J Clin Endocrinol Metab. 2019 Feb 7. pii: 5307688. doi: 10.1210/jc.2018-02261.
    PubMed     Abstract available
    
    
    November 2018
32. BIONDI B
    Peristent Dyslipidemia in Hypothyroid Patients: a Good Marker For Personalized Replacement Therapy?
    J Clin Endocrinol Metab. 2018 Nov 9. pii: 5167367. doi: 10.1210/jc.2018-02302.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: